- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
In this report, we only study liposomal/lipid nanoparticle drug delivery system.
LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
According to our latest study, the global Nanoparticle-Mediated Delivery market size was valued at USD 4704.1 million in 2022 and is forecast to a readjusted size of USD 6001.4 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.
Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.
In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
This report is a detailed and comprehensive analysis for global Nanoparticle-Mediated Delivery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nanoparticle-Mediated Delivery market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nanoparticle-Mediated Delivery market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nanoparticle-Mediated Delivery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Nanoparticle-Mediated Delivery market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nanoparticle-Mediated Delivery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nanoparticle-Mediated Delivery market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, BlueWillow Biologics, NovaSOL, Camurus and Ceramisphere, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Nanoparticle-Mediated Delivery market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biological Origin
Non-Biological Origin
Market segment by Application
Drug Delivery
Gene Delivery
Market segment by players, this report covers
AbbVie
BlueWillow Biologics
NovaSOL
Camurus
Ceramisphere
Celgene, CytImmune
Cristal Therapeutics
EnColl
Lena Nanoceutics Ltd.
EyePoint Pharmaceuticals
Nanobiotix
NanoCarrier
Nanospectra
NanOlogy
Selecta Biosciences
Parvus Therapeutics
Starpharma
Tarveda Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nanoparticle-Mediated Delivery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nanoparticle-Mediated Delivery, with revenue, gross margin and global market share of Nanoparticle-Mediated Delivery from 2018 to 2023.
Chapter 3, the Nanoparticle-Mediated Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nanoparticle-Mediated Delivery market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nanoparticle-Mediated Delivery.
Chapter 13, to describe Nanoparticle-Mediated Delivery research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Nanoparticle-Mediated Delivery
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nanoparticle-Mediated Delivery by Type
1.3.1 Overview: Global Nanoparticle-Mediated Delivery Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Nanoparticle-Mediated Delivery Consumption Value Market Share by Type in 2022
1.3.3 Biological Origin
1.3.4 Non-Biological Origin
1.4 Global Nanoparticle-Mediated Delivery Market by Application
1.4.1 Overview: Global Nanoparticle-Mediated Delivery Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Drug Delivery
1.4.3 Gene Delivery
1.5 Global Nanoparticle-Mediated Delivery Market Size & Forecast
1.6 Global Nanoparticle-Mediated Delivery Market Size and Forecast by Region
1.6.1 Global Nanoparticle-Mediated Delivery Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Nanoparticle-Mediated Delivery Market Size by Region, (2018-2029)
1.6.3 North America Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
1.6.4 Europe Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
1.6.6 South America Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Nanoparticle-Mediated Delivery Product and Solutions
2.1.4 AbbVie Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 BlueWillow Biologics
2.2.1 BlueWillow Biologics Details
2.2.2 BlueWillow Biologics Major Business
2.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Product and Solutions
2.2.4 BlueWillow Biologics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BlueWillow Biologics Recent Developments and Future Plans
2.3 NovaSOL
2.3.1 NovaSOL Details
2.3.2 NovaSOL Major Business
2.3.3 NovaSOL Nanoparticle-Mediated Delivery Product and Solutions
2.3.4 NovaSOL Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 NovaSOL Recent Developments and Future Plans
2.4 Camurus
2.4.1 Camurus Details
2.4.2 Camurus Major Business
2.4.3 Camurus Nanoparticle-Mediated Delivery Product and Solutions
2.4.4 Camurus Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Camurus Recent Developments and Future Plans
2.5 Ceramisphere
2.5.1 Ceramisphere Details
2.5.2 Ceramisphere Major Business
2.5.3 Ceramisphere Nanoparticle-Mediated Delivery Product and Solutions
2.5.4 Ceramisphere Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ceramisphere Recent Developments and Future Plans
2.6 Celgene, CytImmune
2.6.1 Celgene, CytImmune Details
2.6.2 Celgene, CytImmune Major Business
2.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Product and Solutions
2.6.4 Celgene, CytImmune Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Celgene, CytImmune Recent Developments and Future Plans
2.7 Cristal Therapeutics
2.7.1 Cristal Therapeutics Details
2.7.2 Cristal Therapeutics Major Business
2.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
2.7.4 Cristal Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cristal Therapeutics Recent Developments and Future Plans
2.8 EnColl
2.8.1 EnColl Details
2.8.2 EnColl Major Business
2.8.3 EnColl Nanoparticle-Mediated Delivery Product and Solutions
2.8.4 EnColl Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 EnColl Recent Developments and Future Plans
2.9 Lena Nanoceutics Ltd.
2.9.1 Lena Nanoceutics Ltd. Details
2.9.2 Lena Nanoceutics Ltd. Major Business
2.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product and Solutions
2.9.4 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lena Nanoceutics Ltd. Recent Developments and Future Plans
2.10 EyePoint Pharmaceuticals
2.10.1 EyePoint Pharmaceuticals Details
2.10.2 EyePoint Pharmaceuticals Major Business
2.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product and Solutions
2.10.4 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 EyePoint Pharmaceuticals Recent Developments and Future Plans
2.11 Nanobiotix
2.11.1 Nanobiotix Details
2.11.2 Nanobiotix Major Business
2.11.3 Nanobiotix Nanoparticle-Mediated Delivery Product and Solutions
2.11.4 Nanobiotix Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Nanobiotix Recent Developments and Future Plans
2.12 NanoCarrier
2.12.1 NanoCarrier Details
2.12.2 NanoCarrier Major Business
2.12.3 NanoCarrier Nanoparticle-Mediated Delivery Product and Solutions
2.12.4 NanoCarrier Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 NanoCarrier Recent Developments and Future Plans
2.13 Nanospectra
2.13.1 Nanospectra Details
2.13.2 Nanospectra Major Business
2.13.3 Nanospectra Nanoparticle-Mediated Delivery Product and Solutions
2.13.4 Nanospectra Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Nanospectra Recent Developments and Future Plans
2.14 NanOlogy
2.14.1 NanOlogy Details
2.14.2 NanOlogy Major Business
2.14.3 NanOlogy Nanoparticle-Mediated Delivery Product and Solutions
2.14.4 NanOlogy Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 NanOlogy Recent Developments and Future Plans
2.15 Selecta Biosciences
2.15.1 Selecta Biosciences Details
2.15.2 Selecta Biosciences Major Business
2.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Product and Solutions
2.15.4 Selecta Biosciences Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Selecta Biosciences Recent Developments and Future Plans
2.16 Parvus Therapeutics
2.16.1 Parvus Therapeutics Details
2.16.2 Parvus Therapeutics Major Business
2.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
2.16.4 Parvus Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Parvus Therapeutics Recent Developments and Future Plans
2.17 Starpharma
2.17.1 Starpharma Details
2.17.2 Starpharma Major Business
2.17.3 Starpharma Nanoparticle-Mediated Delivery Product and Solutions
2.17.4 Starpharma Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Starpharma Recent Developments and Future Plans
2.18 Tarveda Therapeutics
2.18.1 Tarveda Therapeutics Details
2.18.2 Tarveda Therapeutics Major Business
2.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
2.18.4 Tarveda Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Tarveda Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nanoparticle-Mediated Delivery Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Nanoparticle-Mediated Delivery by Company Revenue
3.2.2 Top 3 Nanoparticle-Mediated Delivery Players Market Share in 2022
3.2.3 Top 6 Nanoparticle-Mediated Delivery Players Market Share in 2022
3.3 Nanoparticle-Mediated Delivery Market: Overall Company Footprint Analysis
3.3.1 Nanoparticle-Mediated Delivery Market: Region Footprint
3.3.2 Nanoparticle-Mediated Delivery Market: Company Product Type Footprint
3.3.3 Nanoparticle-Mediated Delivery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Nanoparticle-Mediated Delivery Consumption Value and Market Share by Type (2018-2023)
4.2 Global Nanoparticle-Mediated Delivery Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Nanoparticle-Mediated Delivery Consumption Value Market Share by Application (2018-2023)
5.2 Global Nanoparticle-Mediated Delivery Market Forecast by Application (2024-2029)
6 North America
6.1 North America Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
6.2 North America Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
6.3 North America Nanoparticle-Mediated Delivery Market Size by Country
6.3.1 North America Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2029)
6.3.2 United States Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
6.3.3 Canada Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
6.3.4 Mexico Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
7.2 Europe Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
7.3 Europe Nanoparticle-Mediated Delivery Market Size by Country
7.3.1 Europe Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2029)
7.3.2 Germany Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
7.3.3 France Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
7.3.5 Russia Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
7.3.6 Italy Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region
8.3.1 Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Region (2018-2029)
8.3.2 China Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
8.3.3 Japan Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
8.3.4 South Korea Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
8.3.5 India Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
8.3.7 Australia Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
9 South America
9.1 South America Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
9.2 South America Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
9.3 South America Nanoparticle-Mediated Delivery Market Size by Country
9.3.1 South America Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2029)
9.3.2 Brazil Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
9.3.3 Argentina Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country
10.3.1 Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2029)
10.3.2 Turkey Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
10.3.4 UAE Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Nanoparticle-Mediated Delivery Market Drivers
11.2 Nanoparticle-Mediated Delivery Market Restraints
11.3 Nanoparticle-Mediated Delivery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Nanoparticle-Mediated Delivery Industry Chain
12.2 Nanoparticle-Mediated Delivery Upstream Analysis
12.3 Nanoparticle-Mediated Delivery Midstream Analysis
12.4 Nanoparticle-Mediated Delivery Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Nanoparticle-Mediated Delivery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nanoparticle-Mediated Delivery Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Nanoparticle-Mediated Delivery Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Nanoparticle-Mediated Delivery Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Nanoparticle-Mediated Delivery Product and Solutions
Table 8. AbbVie Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. BlueWillow Biologics Company Information, Head Office, and Major Competitors
Table 11. BlueWillow Biologics Major Business
Table 12. BlueWillow Biologics Nanoparticle-Mediated Delivery Product and Solutions
Table 13. BlueWillow Biologics Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BlueWillow Biologics Recent Developments and Future Plans
Table 15. NovaSOL Company Information, Head Office, and Major Competitors
Table 16. NovaSOL Major Business
Table 17. NovaSOL Nanoparticle-Mediated Delivery Product and Solutions
Table 18. NovaSOL Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. NovaSOL Recent Developments and Future Plans
Table 20. Camurus Company Information, Head Office, and Major Competitors
Table 21. Camurus Major Business
Table 22. Camurus Nanoparticle-Mediated Delivery Product and Solutions
Table 23. Camurus Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Camurus Recent Developments and Future Plans
Table 25. Ceramisphere Company Information, Head Office, and Major Competitors
Table 26. Ceramisphere Major Business
Table 27. Ceramisphere Nanoparticle-Mediated Delivery Product and Solutions
Table 28. Ceramisphere Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Ceramisphere Recent Developments and Future Plans
Table 30. Celgene, CytImmune Company Information, Head Office, and Major Competitors
Table 31. Celgene, CytImmune Major Business
Table 32. Celgene, CytImmune Nanoparticle-Mediated Delivery Product and Solutions
Table 33. Celgene, CytImmune Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Celgene, CytImmune Recent Developments and Future Plans
Table 35. Cristal Therapeutics Company Information, Head Office, and Major Competitors
Table 36. Cristal Therapeutics Major Business
Table 37. Cristal Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
Table 38. Cristal Therapeutics Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Cristal Therapeutics Recent Developments and Future Plans
Table 40. EnColl Company Information, Head Office, and Major Competitors
Table 41. EnColl Major Business
Table 42. EnColl Nanoparticle-Mediated Delivery Product and Solutions
Table 43. EnColl Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. EnColl Recent Developments and Future Plans
Table 45. Lena Nanoceutics Ltd. Company Information, Head Office, and Major Competitors
Table 46. Lena Nanoceutics Ltd. Major Business
Table 47. Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product and Solutions
Table 48. Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Lena Nanoceutics Ltd. Recent Developments and Future Plans
Table 50. EyePoint Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. EyePoint Pharmaceuticals Major Business
Table 52. EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product and Solutions
Table 53. EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. EyePoint Pharmaceuticals Recent Developments and Future Plans
Table 55. Nanobiotix Company Information, Head Office, and Major Competitors
Table 56. Nanobiotix Major Business
Table 57. Nanobiotix Nanoparticle-Mediated Delivery Product and Solutions
Table 58. Nanobiotix Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Nanobiotix Recent Developments and Future Plans
Table 60. NanoCarrier Company Information, Head Office, and Major Competitors
Table 61. NanoCarrier Major Business
Table 62. NanoCarrier Nanoparticle-Mediated Delivery Product and Solutions
Table 63. NanoCarrier Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. NanoCarrier Recent Developments and Future Plans
Table 65. Nanospectra Company Information, Head Office, and Major Competitors
Table 66. Nanospectra Major Business
Table 67. Nanospectra Nanoparticle-Mediated Delivery Product and Solutions
Table 68. Nanospectra Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Nanospectra Recent Developments and Future Plans
Table 70. NanOlogy Company Information, Head Office, and Major Competitors
Table 71. NanOlogy Major Business
Table 72. NanOlogy Nanoparticle-Mediated Delivery Product and Solutions
Table 73. NanOlogy Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. NanOlogy Recent Developments and Future Plans
Table 75. Selecta Biosciences Company Information, Head Office, and Major Competitors
Table 76. Selecta Biosciences Major Business
Table 77. Selecta Biosciences Nanoparticle-Mediated Delivery Product and Solutions
Table 78. Selecta Biosciences Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Selecta Biosciences Recent Developments and Future Plans
Table 80. Parvus Therapeutics Company Information, Head Office, and Major Competitors
Table 81. Parvus Therapeutics Major Business
Table 82. Parvus Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
Table 83. Parvus Therapeutics Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Parvus Therapeutics Recent Developments and Future Plans
Table 85. Starpharma Company Information, Head Office, and Major Competitors
Table 86. Starpharma Major Business
Table 87. Starpharma Nanoparticle-Mediated Delivery Product and Solutions
Table 88. Starpharma Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Starpharma Recent Developments and Future Plans
Table 90. Tarveda Therapeutics Company Information, Head Office, and Major Competitors
Table 91. Tarveda Therapeutics Major Business
Table 92. Tarveda Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
Table 93. Tarveda Therapeutics Nanoparticle-Mediated Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Tarveda Therapeutics Recent Developments and Future Plans
Table 95. Global Nanoparticle-Mediated Delivery Revenue (USD Million) by Players (2018-2023)
Table 96. Global Nanoparticle-Mediated Delivery Revenue Share by Players (2018-2023)
Table 97. Breakdown of Nanoparticle-Mediated Delivery by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Nanoparticle-Mediated Delivery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Nanoparticle-Mediated Delivery Players
Table 100. Nanoparticle-Mediated Delivery Market: Company Product Type Footprint
Table 101. Nanoparticle-Mediated Delivery Market: Company Product Application Footprint
Table 102. Nanoparticle-Mediated Delivery New Market Entrants and Barriers to Market Entry
Table 103. Nanoparticle-Mediated Delivery Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Nanoparticle-Mediated Delivery Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Nanoparticle-Mediated Delivery Consumption Value Share by Type (2018-2023)
Table 106. Global Nanoparticle-Mediated Delivery Consumption Value Forecast by Type (2024-2029)
Table 107. Global Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2023)
Table 108. Global Nanoparticle-Mediated Delivery Consumption Value Forecast by Application (2024-2029)
Table 109. North America Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Nanoparticle-Mediated Delivery Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Nanoparticle-Mediated Delivery Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Nanoparticle-Mediated Delivery Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Nanoparticle-Mediated Delivery Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Nanoparticle-Mediated Delivery Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Nanoparticle-Mediated Delivery Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Nanoparticle-Mediated Delivery Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Nanoparticle-Mediated Delivery Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Nanoparticle-Mediated Delivery Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Nanoparticle-Mediated Delivery Raw Material
Table 140. Key Suppliers of Nanoparticle-Mediated Delivery Raw Materials
List of Figures
Figure 1. Nanoparticle-Mediated Delivery Picture
Figure 2. Global Nanoparticle-Mediated Delivery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nanoparticle-Mediated Delivery Consumption Value Market Share by Type in 2022
Figure 4. Biological Origin
Figure 5. Non-Biological Origin
Figure 6. Global Nanoparticle-Mediated Delivery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Nanoparticle-Mediated Delivery Consumption Value Market Share by Application in 2022
Figure 8. Drug Delivery Picture
Figure 9. Gene Delivery Picture
Figure 10. Global Nanoparticle-Mediated Delivery Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Nanoparticle-Mediated Delivery Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Nanoparticle-Mediated Delivery Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Nanoparticle-Mediated Delivery Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Nanoparticle-Mediated Delivery Consumption Value Market Share by Region in 2022
Figure 15. North America Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Nanoparticle-Mediated Delivery Revenue Share by Players in 2022
Figure 21. Nanoparticle-Mediated Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Nanoparticle-Mediated Delivery Market Share in 2022
Figure 23. Global Top 6 Players Nanoparticle-Mediated Delivery Market Share in 2022
Figure 24. Global Nanoparticle-Mediated Delivery Consumption Value Share by Type (2018-2023)
Figure 25. Global Nanoparticle-Mediated Delivery Market Share Forecast by Type (2024-2029)
Figure 26. Global Nanoparticle-Mediated Delivery Consumption Value Share by Application (2018-2023)
Figure 27. Global Nanoparticle-Mediated Delivery Market Share Forecast by Application (2024-2029)
Figure 28. North America Nanoparticle-Mediated Delivery Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Nanoparticle-Mediated Delivery Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Nanoparticle-Mediated Delivery Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Nanoparticle-Mediated Delivery Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Nanoparticle-Mediated Delivery Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Nanoparticle-Mediated Delivery Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 38. France Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value Market Share by Region (2018-2029)
Figure 45. China Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 48. India Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Nanoparticle-Mediated Delivery Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Nanoparticle-Mediated Delivery Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Nanoparticle-Mediated Delivery Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Nanoparticle-Mediated Delivery Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Nanoparticle-Mediated Delivery Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Nanoparticle-Mediated Delivery Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Nanoparticle-Mediated Delivery Consumption Value (2018-2029) & (USD Million)
Figure 62. Nanoparticle-Mediated Delivery Market Drivers
Figure 63. Nanoparticle-Mediated Delivery Market Restraints
Figure 64. Nanoparticle-Mediated Delivery Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Nanoparticle-Mediated Delivery in 2022
Figure 67. Manufacturing Process Analysis of Nanoparticle-Mediated Delivery
Figure 68. Nanoparticle-Mediated Delivery Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
